AKT1 and prostate carcinoma: In contrast, miR-652 expression in LNCaP prostate cancer cells induced NED through a pathway initiated by PPP2R3A inhibition, resulting in increased AKT, ERK-1/2 and Wnt activation, loss of AR, with gene transcription via activated β-catenin.